Bionano Genomics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Bionano Genomics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Bionano Genomics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.83M, a 54.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.83M -$3.34M -54.1% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $4.22M -$2.48M -37% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $4.87M -$2.19M -31% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $5.63M -$1.59M -22% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $6.17M +$140K +2.32% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $6.7M +$266K +4.14% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $7.06M +$245K +3.59% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $7.22M +$531K +7.94% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $6.03M Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $6.43M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $6.82M Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $6.69M +$6.69M Dec 31, 2021 10-K 2023-03-09
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.